|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 72.52 EUR | +0.42% |
|
+1.48% | +4.23% |
| 01-16 | DAX Index Ends Week in Red; German Inflation Eases | MT |
| 01-16 | HENKEL VORZUEGE : JP Morgan reaffirms its Sell rating | ZD |
| Capitalization | 28.36B 32.9B 26.4B 24.58B 45.77B 2,985B 49.24B 304B 120B 1,424B 123B 121B 5,200B | P/E ratio 2025 * |
14.6x | P/E ratio 2026 * | 14.1x |
|---|---|---|---|---|---|
| Enterprise value | 27.99B 32.46B 26.05B 24.25B 45.16B 2,945B 48.59B 300B 118B 1,405B 122B 119B 5,130B | EV / Sales 2025 * |
1.36x | EV / Sales 2026 * | 1.3x |
| Free-Float |
59.08% | Yield 2025 * |
2.9% | Yield 2026 * | 3% |
Last Transcript: Henkel AG & Co. KGaA
| 1 day | +0.42% | ||
| 1 week | +1.48% | ||
| Current month | +4.23% | ||
| 1 month | +3.10% | ||
| 3 months | +2.34% | ||
| 6 months | +7.06% | ||
| Current year | +4.23% |
| 1 week | 70.66 | 72.72 | |
| 1 month | 68.28 | 72.72 | |
| Current year | 68.28 | 72.72 | |
| 1 year | 65.54 | 88.5 | |
| 3 years | 64.06 | 88.5 | |
| 5 years | 56.56 | 99.5 | |
| 10 years | 56.56 | 129.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Carsten Knobel
CEO | Chief Executive Officer | 57 | 31/12/2019 |
Marco Swoboda
DFI | Director of Finance/CFO | 54 | 31/12/2019 |
Michael Nilles
CTO | Chief Tech/Sci/R&D Officer | 52 | 31/12/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 13/04/2008 | |
Andrea Pichottka
BRD | Director/Board Member | 66 | 25/10/2004 |
Edgar Topsch
BRD | Director/Board Member | 65 | 31/07/2010 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.42% | +1.48% | -12.05% | +10.68% | 32.9B | ||
| -4.65% | -7.54% | -2.70% | -18.40% | 3.28B | ||
| +1.94% | +3.46% | +76.27% | +3.54% | 2.26B | ||
| +0.69% | +0.10% | - | - | 1.95B | ||
| +1.62% | +6.33% | +58.90% | +122.77% | 1.95B | ||
| +8.70% | +6.14% | +40.82% | - | 1.72B | ||
| -1.34% | +4.66% | +33.33% | +56.29% | 1.32B | ||
| +1.43% | +2.35% | +57.98% | +31.73% | 1.28B | ||
| -1.08% | -0.77% | +0.16% | +141.73% | 1.23B | ||
| -3.36% | -0.04% | +167.43% | +218.69% | 1.11B | ||
| Average | +0.44% | +1.24% | +46.68% | +70.88% | 4.9B | |
| Weighted average by Cap. | +0.36% | +1.11% | +5.45% | +23.59% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 20.63B 23.93B 19.21B 17.88B 33.29B 2,171B 35.82B 221B 87.12B 1,036B 89.75B 87.9B 3,782B | 20.74B 24.06B 19.31B 17.97B 33.46B 2,183B 36B 222B 87.56B 1,041B 90.21B 88.35B 3,802B |
| Net income | 2.05B 2.38B 1.91B 1.78B 3.31B 216B 3.56B 21.96B 8.66B 103B 8.92B 8.74B 376B | 2.1B 2.44B 1.96B 1.82B 3.39B 221B 3.65B 22.49B 8.87B 105B 9.14B 8.95B 385B |
| Net Debt | -379M -439M -353M -328M -611M -39.87B -658M -4.06B -1.6B -19.02B -1.65B -1.61B -69.44B | -1.49B -1.73B -1.39B -1.29B -2.41B -157B -2.59B -15.96B -6.29B -74.84B -6.48B -6.35B -273B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/01/26 | 72.52 € | +0.42% | 534,708 |
| 15/01/26 | 72.22 € | -0.39% | 457,775 |
| 14/01/26 | 72.50 € | +1.77% | 480,797 |
| 13/01/26 | 71.24 € | -0.31% | 338,154 |
| 12/01/26 | 71.46 € | 0.00% | 387,042 |
Delayed Quote Xetra, January 16, 2026 at 04:39 pm
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HEN3 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















